Company / EPS (Diluted)
Elevance Health EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$25.21
FY2025
5-year range
$17.98 / $25.21
FY2021-FY2025
Trend
+3.8%
vs FY2024
Sector context
#4 of 159
Health Care
What the data says
Among 159 Health Care companies, Elevance Health is in the top 3% for eps (diluted). EPS (Diluted) has fluctuated over the past 10 years, ranging from $9.21 in FY2016 to $25.21 in FY2025.
Based on SEC 10-K filings.
25.21 in FY2025 with a 5-year CAGR of +7.0%. Top quartile in the Health Care sector.
Remained stable around $25.21 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +11.9%
- 5-Year CAGR
- +7.0%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 159This company $25.21 Sector average $2.35
▼
+971.8% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 3.8% year-over-year.
- Ranks #4 out of 159 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2016.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $25.21 | +3.8% |
| FY2024 | $24.28 | -2.7% |
| FY2023 | $24.95 | +38.8% |
| FY2022 | $17.98 | -2.7% |
| FY2021 | $18.47 | +2.7% |
| FY2020 | $17.98 | +25.3% |
| FY2019 | $14.35 | +1.1% |
| FY2018 | $14.19 | +51.3% |
| FY2017 | $9.38 | +1.8% |
| FY2016 | $9.21 | +12.3% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026